Zhang L - Search Results

1

Large-scale production, purification, and function of a tumor multi-epitope vaccine: Peptibody with bFGF/VEGFA.

Zhang L, Jiang C, Chen X, Gu J, Song Q, Zhong H, Xiong S, Dong Q, Yu JC, Deng N. Zhang L, et al. Eng Life Sci. 2020 Jul 29;20(9-10):422-436. doi: 10.1002/elsc.202000020. eCollection 2020 Sep. Eng Life Sci. 2020. PMID: 32944017 Free PMC article.

2

Fine epitope mapping of a human disulphide-stabilized diabody against fibroblast growth factor-2.

Zhong J, Zhang S, Zhang L, Cai Y, Deng Y, Zheng Q, Deng N. Zhong J, et al. Among authors: zhang l, zhang s. J Biochem. 2019 Jun 1;165(6):487-495. doi: 10.1093/jb/mvy122. J Biochem. 2019. PMID: 30597085

3

Fermentation, purification and immunogenicity of a recombinant tumor multi-epitope vaccine, VBP3.

Zhang L, Chen X, Deng Y, Jiang C, Deng N. Zhang L, et al. Protein Expr Purif. 2020 Oct;174:105658. doi: 10.1016/j.pep.2020.105658. Epub 2020 Apr 28. Protein Expr Purif. 2020. PMID: 32360598

4

miR-6086 inhibits ovarian cancer angiogenesis by downregulating the OC2/VEGFA/EGFL6 axis.

Wu B, Zhang L, Yu Y, Lu T, Zhang Y, Zhu W, Song Q, Lv C, Guo J, Tian Y, Deng N. Wu B, et al. Among authors: zhang l, zhang y. Cell Death Dis. 2020 May 11;11(5):345. doi: 10.1038/s41419-020-2501-5. Cell Death Dis. 2020. PMID: 32393810 Free PMC article.

5

The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA.

Zhang L, Deng Y, Zhang Y, Liu C, Zhang S, Zhu W, Tang Y, Deng N. Zhang L, et al. Among authors: zhang s, zhang y. Front Oncol. 2020 Jul 17;10:1190. doi: 10.3389/fonc.2020.01190. eCollection 2020. Front Oncol. 2020. Retraction in: Front Oncol. 2021 Jan 15;10:644690. doi: 10.3389/fonc.2020.644690 PMID: 32766160 Free PMC article. Retracted.

6

Barriers and Strategies of Cationic Liposomes for Cancer Gene Therapy.

Liu C, Zhang L, Zhu W, Guo R, Sun H, Chen X, Deng N. Liu C, et al. Among authors: zhang l. Mol Ther Methods Clin Dev. 2020 Jul 31;18:751-764. doi: 10.1016/j.omtm.2020.07.015. eCollection 2020 Sep 11. Mol Ther Methods Clin Dev. 2020. PMID: 32913882 Free PMC article. Review.

7

CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer.

Lu T, Zhang L, Zhu W, Zhang Y, Zhang S, Wu B, Deng N. Lu T, et al. Among authors: zhang l, zhang s, zhang y. Front Oncol. 2020 Sep 2;10:1529. doi: 10.3389/fonc.2020.01529. eCollection 2020. Front Oncol. 2020. Retraction in: Front Oncol. 2021 May 10;11:694036. doi: 10.3389/fonc.2021.694036 PMID: 32984003 Free PMC article. Retracted.

8

Fermentation, Purification, and Tumor Inhibition of a Disulfide-Stabilized Diabody Against Fibroblast Growth Factor-2.

Zhang S, Huang J, Zhang L, Gu J, Song Q, Cai Y, Zhong J, Zhong H, Deng Y, Zhu W, Zhao J, Deng N. Zhang S, et al. Among authors: zhang l. Front Oncol. 2021 Feb 25;11:585457. doi: 10.3389/fonc.2021.585457. eCollection 2021. Front Oncol. 2021. PMID: 33718141 Free PMC article.

9

Soluble expression of bioactive recombinant porcine-human chimeric uricase mutant employing MBP-SUMO fusion system.

Zhou Z, Zhao H, Zhang L, Xie Q, Liu Q, Tong M, Yu X, Xiong S. Zhou Z, et al. Among authors: zhang l. Protein Expr Purif. 2022 Jan;189:105978. doi: 10.1016/j.pep.2021.105978. Epub 2021 Sep 22. Protein Expr Purif. 2022. PMID: 34562586

10

Preparation of DSPE-PEG-cRGD Modified Cationic Liposomes for Delivery of OC-2 shRNA and The Antitumor Effects on Breast Cancer.

Liu C, Zhao W, Zhang L, Sun H, Chen X, Deng N. Liu C, et al. Among authors: zhang l. Pharmaceutics. 2022 Oct 10;14(10):2157. doi: 10.3390/pharmaceutics14102157. Pharmaceutics. 2022. PMID: 36297592 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134,872 results

Search Page

Filters